BethLabQueen said:Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data: Category Marker Before After…
Careful with treating an unchanged LDL-C as a failure. If ApoB and triglycerides both fell, the particle picture improved regardless of what the calculated LDL says.
LipidDoc_ATL said:Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.
Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:
| Marker | Baseline | Month 8 | Clinical Meaning |
|---|---|---|---|
| LDL-P | 1586 | 986 | Particle count (more precise than LDL-C) |
| Small dense LDL | 61% | 30% | Atherogenic pattern |
| Remnant cholesterol | 38 | 15 | Triglyceride-rich lipoproteins |
| oxLDL | 71 | 44 | Oxidative stress marker |
The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.
LarryQC_SD said:Careful with treating an unchanged LDL-C as a failure.
Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 4.4% to 7.9% over 9 months. I supplemented with 2g EPA+DHA daily.
This matters because omega-3s are anti-inflammatory and cardioprotective, complementing the GLP-1 benefits. Target omega-3 index is >8%. Combined with the triglyceride reduction from the medication, my lipid profile is the best it's been in decades.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOP back with an update, since a thread like this is useless without one.
Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.